Insulet Financial Statements From 2010 to 2025

PODD Stock  USD 320.35  0.53  0.17%   
Insulet's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Insulet's valuation are provided below:
Gross Profit
1.8 B
Profit Margin
0.0976
Market Capitalization
22.5 B
Enterprise Value Revenue
9.4323
Revenue
2.5 B
There are over one hundred nineteen available fundamental trends for Insulet, which can be analyzed over time and compared to other ratios. Investors should ensure to confirm all of Insulet's regular performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 9.8 B. The current year's Enterprise Value is expected to grow to about 10.5 B

Insulet Total Revenue

2.18 Billion

Check Insulet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insulet's main balance sheet or income statement drivers, such as Interest Expense of 44.8 M, Other Operating Expenses of 1.9 B or Operating Income of 324.3 M, as well as many indicators such as Price To Sales Ratio of 15.94, Dividend Yield of 0.0 or PTB Ratio of 19.9. Insulet financial statements analysis is a perfect complement when working with Insulet Valuation or Volatility modules.
  
Build AI portfolio with Insulet Stock
Check out the analysis of Insulet Correlation against competitors.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

Insulet Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.2 B3.1 B1.2 B
Slightly volatile
CashB953.4 M416.5 M
Slightly volatile
Other Assets1.091.1525.6 M
Slightly volatile
Cash And Short Term InvestmentsB953.4 M441.8 M
Slightly volatile
Common Stock Shares Outstanding46.3 M73.9 M56.1 M
Slightly volatile
Liabilities And Stockholders Equity3.2 B3.1 B1.2 B
Slightly volatile
Total LiabilitiesB1.9 B876.5 M
Slightly volatile
Total Current AssetsB1.9 B755.5 M
Slightly volatile
Short and Long Term Debt Total1.5 B1.4 B701.6 M
Slightly volatile
Total Current Liabilities554.8 M528.4 M186.2 M
Slightly volatile
Short Term Debt52.6 M85.9 M54.7 M
Very volatile
Property Plant And Equipment Net797.8 M759.8 M303.9 M
Slightly volatile
Accounts Payable19.8 M19.8 M23.1 M
Slightly volatile
Non Current Assets Total1.3 B1.2 B477.6 M
Slightly volatile
Non Currrent Assets Other167.4 M159.4 M59.7 M
Slightly volatile
Common Stock Total Equity120.8 K115 K73.4 K
Slightly volatile
Non Current Liabilities Total1.4 B1.3 B692.4 M
Slightly volatile
Property Plant And Equipment Gross1.1 B1.1 B386.4 M
Slightly volatile
Common Stock61.9 K115 K69.7 K
Slightly volatile
Other Liabilities5.4 M9.5 M6.5 M
Slightly volatile
Long Term Debt1.4 B1.3 B671.5 M
Slightly volatile
Net Receivables383.8 M365.5 M123.3 M
Slightly volatile
Inventory451.9 M430.4 M149.6 M
Slightly volatile
Property Plant Equipment724.4 M689.9 M287.8 M
Slightly volatile
Good Will45 M51.5 M40.2 M
Slightly volatile
Long Term Debt Total1.7 B1.6 B715.2 M
Slightly volatile
Capital Surpluse899.1 M1.2 B841 M
Slightly volatile
Non Current Liabilities Other54.2 M51.6 M16.8 M
Slightly volatile
Intangible Assets103.4 M98.5 M36.5 M
Slightly volatile
Capital Lease Obligations230 K242.1 K1.7 M
Slightly volatile
Short and Long Term Debt129.8 M96 M143.7 M
Slightly volatile
Net Invested Capital1.6 B2.6 B1.1 B
Slightly volatile
Net Working Capital937.2 M1.4 B681.9 M
Slightly volatile
Capital Stock103.6 K115 K78.1 K
Slightly volatile

Insulet Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses1.9 B1.8 B725.1 M
Slightly volatile
Research Development230.6 M219.6 M102.6 M
Slightly volatile
Total Operating Expenses1.2 B1.1 B450.2 M
Slightly volatile
Selling And Marketing Expenses74.5 M84.3 M73.8 M
Pretty Stable
Depreciation And Amortization84.8 M80.8 M34.1 M
Slightly volatile
Selling General Administrative874.5 M832.9 M278.1 M
Slightly volatile
Total Revenue2.2 B2.1 B784.3 M
Slightly volatile
Cost Of Revenue657.2 M625.9 M275 M
Slightly volatile
Interest Income41.5 M39.5 M14.5 M
Slightly volatile
Reconciled Depreciation52.9 M80.8 M33.4 M
Slightly volatile

Insulet Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow739.4 M704.2 M330.7 M
Slightly volatile
Depreciation84.8 M80.8 M34.1 M
Slightly volatile
Capital Expenditures131.1 M124.9 M79.1 M
Slightly volatile
End Period Cash FlowB953.4 M400.8 M
Slightly volatile
Change To Liabilities158.8 M151.2 M46.9 M
Slightly volatile
Stock Based Compensation72.8 M69.3 M31.1 M
Slightly volatile
Change To Netincome40.7 M55.1 M37.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio15.948.831215.8662
Slightly volatile
Days Sales Outstanding73.4464.398358.3498
Pretty Stable
Stock Based Compensation To Revenue0.0590.03350.0534
Slightly volatile
Capex To Depreciation1.471.54583.0181
Pretty Stable
EV To Sales17.889.057418.3106
Slightly volatile
Inventory Turnover1.381.45424.8261
Slightly volatile
Days Of Inventory On Hand264251147
Slightly volatile
Payables Turnover33.1931.611112.6616
Slightly volatile
Sales General And Administrative To Revenue0.320.360.3943
Slightly volatile
Research And Ddevelopement To Revenue0.10.10613.5818
Slightly volatile
Capex To Revenue0.05730.06036.9375
Slightly volatile
Cash Per Share16.3613.605210.598
Very volatile
Days Payables Outstanding10.9711.546659.9642
Slightly volatile
Intangibles To Total Assets0.04620.04860.1171
Slightly volatile
Current Ratio3.363.541328.6805
Slightly volatile
Receivables Turnover4.985.66796.9512
Very volatile
Graham Number50.648.188710.0866
Slightly volatile
Capex Per Share3.181.78241.8955
Very volatile
Average Receivables24.6 M29.9 M31.5 M
Very volatile
Revenue Per Share31.0429.562212.0268
Slightly volatile
Interest Debt Per Share21.9520.901611.2229
Slightly volatile
Debt To Assets0.420.46050.5559
Slightly volatile
Operating Cycle269315256
Very volatile
Days Of Payables Outstanding10.9711.546659.9642
Slightly volatile
Ebt Per Ebit1.570.97181.4314
Slightly volatile
Quick Ratio2.592.726728.1043
Slightly volatile
Net Income Per E B T1.051.39340.9559
Pretty Stable
Cash Ratio1.711.804326.9732
Slightly volatile
Cash Conversion Cycle201304193
Very volatile
Days Of Inventory Outstanding264251147
Slightly volatile
Days Of Sales Outstanding73.4464.398358.3498
Pretty Stable
Fixed Asset Turnover4.412.72654.3503
Slightly volatile
Debt Ratio0.420.46050.5559
Slightly volatile
Price Sales Ratio15.948.831215.8662
Slightly volatile
Asset Turnover0.460.67090.6612
Pretty Stable

Insulet Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.8 B9.3 B6.9 B
Slightly volatile
Enterprise Value10.5 B10 B7.4 B
Slightly volatile

Insulet Fundamental Market Drivers

Forward Price Earnings54.9451
Cash And Short Term Investments953.4 M

Insulet Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Insulet Financial Statements

Insulet stakeholders use historical fundamental indicators, such as Insulet's revenue or net income, to determine how well the company is positioned to perform in the future. Although Insulet investors may analyze each financial statement separately, they are all interrelated. For example, changes in Insulet's assets and liabilities are reflected in the revenues and expenses on Insulet's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Insulet. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue12 M12.6 M
Total Revenue2.1 B2.2 B
Cost Of Revenue625.9 M657.2 M
Stock Based Compensation To Revenue 0.03  0.06 
Sales General And Administrative To Revenue 0.36  0.32 
Research And Ddevelopement To Revenue 0.11  0.10 
Capex To Revenue 0.06  0.06 
Revenue Per Share 29.56  31.04 
Ebit Per Revenue 0.15  0.16 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:
Check out the analysis of Insulet Correlation against competitors.
For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.148
Earnings Share
3.42
Revenue Per Share
35.873
Quarterly Revenue Growth
0.299
Return On Assets
0.0874
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.